José Antônio Marin‐Neto

Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy

Carlos A. Morillo, José Antônio Marin‐Neto, Álvaro Avezum et al. · New England Journal of Medicine · 2015 · 1K citations · Full text

Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.

Vasken Dilsizian, James A. Arrighi, Jean G. Diodati et al. · Circulation · 1994 · 273 citations · Full text

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)

José Antônio Marin‐Neto, Anis Rassi, Carlos A. Morillo et al. · American Heart Journal · 2008 · 209 citations

African Trypanosomiasis, Medicine, Benznidazole Evaluation +4

Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification

Anis Rassi, Anis Rassi, José Antônio Marin‐Neto · Memórias do Instituto Oswaldo Cruz · 2009 · 195 citations · Full text

Heart Failure, Immunology, Gastroenterology +19

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

José Antônio Marin‐Neto, Anis Rassi, Álvaro Avezum et al. · Memórias do Instituto Oswaldo Cruz · 2009 · 180 citations · Full text